Journal of cardiology最新文献

筛选
英文 中文
How to demonstrate clinical implication of ECPELLA strategy in patients with acute myocardial infarction complicated with cardiogenic shock. 如何证明 ECPELLA 策略对急性心肌梗死并发心源性休克患者的临床意义。
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-03-01 DOI: 10.1016/j.jjcc.2025.02.019
Masaki Nakagaito, Teruhiko Imamura
{"title":"How to demonstrate clinical implication of ECPELLA strategy in patients with acute myocardial infarction complicated with cardiogenic shock.","authors":"Masaki Nakagaito, Teruhiko Imamura","doi":"10.1016/j.jjcc.2025.02.019","DOIUrl":"10.1016/j.jjcc.2025.02.019","url":null,"abstract":"","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D mapping quest: How far can we see with recent advances in 3D mapping? 3D地图探索:我们能看到3D地图的最新进展吗?
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-03-01 DOI: 10.1016/j.jjcc.2024.11.010
Tetsuma Kawaji MD, PhD , Tatsuya Hayashi MD, PhD , Takuro Nishimura MD, PhD , Koichi Nagashima MD, PhD
{"title":"3D mapping quest: How far can we see with recent advances in 3D mapping?","authors":"Tetsuma Kawaji MD, PhD ,&nbsp;Tatsuya Hayashi MD, PhD ,&nbsp;Takuro Nishimura MD, PhD ,&nbsp;Koichi Nagashima MD, PhD","doi":"10.1016/j.jjcc.2024.11.010","DOIUrl":"10.1016/j.jjcc.2024.11.010","url":null,"abstract":"<div><div>Recent advances in three-dimensional (3D) ultra-high-density mapping systems have uncovered previously unknown mechanisms underlying various arrhythmias. This clinical review, titled “3D Mapping Quest,” focuses on the recently uncovered mechanisms of four types of arrhythmias. (1) To elucidate the precise mechanisms underlying atrial fibrillation (AF), ultra-high-density mapping with adequate spatial and temporal resolution is essential. Various mapping systems have been employed to investigate the chaotic activation during AF. The question remains: Is the AF driver characterized by focal activation or rotational activation? A novel mapping strategy is expected to provide the answer. (2) In atrioventricular nodal reentrant tachycardia (AVNRTs), 3D mapping revealed that the pivot point of activation at the lower end of a functional block line extending vertically downward from the His-bundle area, or a fractionated potential observed during AVNRT, can be targeted for slow pathway ablation. Either approach may prevent unnecessary radiofrequency applications while maintaining the success rate. (3) In premature ventricular contractions originating from the left ventricular summit, 3D mapping has enabled precise identification of the optimal endocardial ablation sites. By performing long-duration ablation at these optimal endocardial sites, the ablation outcomes have improved. (4) In scar-related reentrant ventricular tachycardia (VT), substrate mapping focusing on wavefront discontinuity has allowed for the identification of specific ablation targets within the broad scar. High-density VT activation mapping has revealed the complexity of the circuit structure, such as the 3D VT circuit. The VT circuit delineation on the cardiac surface is conceptualized as a cross-section of a hyperboloid model. Thus, it is anticipated that integrating histological and electrophysiological insights with advanced ultra-high-density mapping technologies will further facilitate a comprehensive understanding of the mechanisms.</div></div>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":"85 3","pages":"Pages 204-212"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring 通过心脏植入式电子设备监测评估 SGLT2 抑制剂对慢性心力衰竭患者室性心律失常负荷的影响。
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-03-01 DOI: 10.1016/j.jjcc.2024.09.005
Paolo Basile MD , Francesco Monitillo MD, PhD , Daniela Santoro MD, PhD , Giorgia Falco MD , Maria Cristina Carella MD , Yamna Khan MD , Arcangelo Moretti MD , Vincenzo Ezio Santobuono MD, PhD , Riccardo Memeo MD , Gianluca Pontone MD, PhD , Cinzia Forleo MD, PhD , Marco Matteo Ciccone MD, PhD , Andrea Igoren Guaricci MD, PhD
{"title":"Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring","authors":"Paolo Basile MD ,&nbsp;Francesco Monitillo MD, PhD ,&nbsp;Daniela Santoro MD, PhD ,&nbsp;Giorgia Falco MD ,&nbsp;Maria Cristina Carella MD ,&nbsp;Yamna Khan MD ,&nbsp;Arcangelo Moretti MD ,&nbsp;Vincenzo Ezio Santobuono MD, PhD ,&nbsp;Riccardo Memeo MD ,&nbsp;Gianluca Pontone MD, PhD ,&nbsp;Cinzia Forleo MD, PhD ,&nbsp;Marco Matteo Ciccone MD, PhD ,&nbsp;Andrea Igoren Guaricci MD, PhD","doi":"10.1016/j.jjcc.2024.09.005","DOIUrl":"10.1016/j.jjcc.2024.09.005","url":null,"abstract":"<div><h3>Background</h3><div>Sodium-glucose cotransporter 2 (SGLT2) inhibitors have revolutionized the therapeutic scenario of heart failure, demonstrating favorable effects on mortality and quality of life. Previous studies have yielded conflicting data regarding the effects on ventricular arrhythmias.</div></div><div><h3>Methods</h3><div>A prospective observational study was conducted to investigate the anti-arrhythmic properties of SGLT2 inhibitors evaluating the intra-patient difference in major adverse arrhythmic cardiac events (MAACE) over a six-month period in patients with chronic heart failure who were undergoing continuous monitoring using a cardiac implantable electronic device.</div></div><div><h3>Results</h3><div>From January 2022 to January 2023, 82 patients [median age 63 years (IQR 15), male 87 %] were enrolled in the study, with a median follow-up of 28 weeks (IQR 5). The rate of MAACE at baseline was 11 %, without relevant differences in the follow up in terms of major and minor arrhythmic events. In patients with an arrhythmic phenotype at baseline, a mild but non statistically significant reduction of MAACE (from 36 % to 28 %, <em>p</em> = 0.727) was observed and a significant decrease of non-sustained ventricular tachycardia (from 68 % to 32 %, <em>p</em> = 0.022).</div></div><div><h3>Conclusions</h3><div>Our findings suggest potential anti-arrhythmic properties of SGLT2 inhibitors, evident in patients with arrhythmic events before the initiation of the drug.</div></div>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":"85 3","pages":"Pages 229-234"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142288049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A nationwide propensity score-matched study Goreisan(一种日本草本锦囊药)的辅助使用与心衰再入院之间的关系:一项全国范围的倾向得分匹配研究。
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-03-01 DOI: 10.1016/j.jjcc.2024.09.010
Toshiaki Isogai MD, MPH , Kojiro Morita PhD, MPH, RN, PHN , Akira Okada MD, MPH, PhD , Nobuaki Michihata MD, MPH, PhD , Hiroki Matsui PhD, MPH , Atsushi Miyawaki MD, PhD , Taisuke Jo MD, PhD , Hideo Yasunaga MD, PhD
{"title":"Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A nationwide propensity score-matched study","authors":"Toshiaki Isogai MD, MPH ,&nbsp;Kojiro Morita PhD, MPH, RN, PHN ,&nbsp;Akira Okada MD, MPH, PhD ,&nbsp;Nobuaki Michihata MD, MPH, PhD ,&nbsp;Hiroki Matsui PhD, MPH ,&nbsp;Atsushi Miyawaki MD, PhD ,&nbsp;Taisuke Jo MD, PhD ,&nbsp;Hideo Yasunaga MD, PhD","doi":"10.1016/j.jjcc.2024.09.010","DOIUrl":"10.1016/j.jjcc.2024.09.010","url":null,"abstract":"<div><h3>Background</h3><div>Goreisan, a Japanese herbal medicine, possesses aquaretic properties to regulate body fluid homeostasis and may therefore be effective as a complement to standard therapy in improving outcomes in patients with heart failure (HF).</div></div><div><h3>Methods</h3><div>We retrospectively identified 431,393 patients (mean age 79.2 ± 12.6 years; male 52.3 %) who were admitted for HF for the first time and were discharged alive with standard HF medications between April 2016 and March 2022, using the Japanese Diagnosis Procedure Combination database. We divided patients into two groups according to the prescription of Goreisan at discharge: patients who received standard HF medications plus Goreisan and those who received standard medications alone. We compared the incidence of HF readmission within 1 year after discharge between the groups using propensity score matching.</div></div><div><h3>Results</h3><div>Overall, Goreisan was prescribed in 1957 (0.45 %) patients at discharge. Patients who received Goreisan were older and received diuretics more frequently than those who did not. One-to-four propensity score matching created a cohort of 1957 and 7828 patients treated with and without Goreisan, respectively. No significant difference was found in the incidence of 1-year HF readmission between the groups [22.1 % vs. 21.7 %; hazard ratio (HR) = 1.02, 95 % confidence interval (CI) = 0.92–1.13]. This result was consistent with that from competing risk analysis (subdistribution HR = 1.02, 95 % CI = 0.92–1.13) and across clinically relevant subgroups except for renal disease. Goreisan use was associated with a lower incidence of HF readmission among patients with renal disease (HR = 0.77, 95 % CI = 0.60–0.97), but not among those without (HR = 1.09, 95 % CI = 0.97–1.23; <em>p</em> for interaction = 0.009).</div></div><div><h3>Conclusions</h3><div>This nationwide propensity score-matched analysis did not demonstrate that complementary Goreisan use at discharge was associated with a lower incidence of 1-year HF readmission in patients with HF receiving standard medications. An ongoing randomized trial is awaited to establish the effectiveness of Goreisan use in patients with HF.</div></div>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":"85 3","pages":"Pages 220-228"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of hypochloremia at the time of discharge to predict prognosis in patients with chronic heart failure after hospitalization 出院时的低氯血症对慢性心力衰竭患者住院后预后的预测作用。
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-03-01 DOI: 10.1016/j.jjcc.2024.08.011
Kayo Misumi MD, PhD , Yuya Matsue MD, PhD , Kazutaka Nogi MD, PhD , Yudai Fujimoto MD , Nobuyuki Kagiyama MD, PhD , Takatoshi Kasai MD, PhD, FJCC , Takeshi Kitai MD, PhD , Shogo Oishi MD , Eiichi Akiyama MD , Satoshi Suzuki MD, PhD, FJCC , Masayoshi Yamamoto MD, PhD , Keisuke Kida MD, PhD, FJCC , Takahiro Okumura MD, PhD, FJCC , Maki Nogi MD, PhD , Satomi Ishihara MD, PhD , Tomoya Ueda MD, PhD , Rika Kawakami MD, PhD, FJCC , Yoshihiko Saito MD, PhD, FJCC , Tohru Minamino MD, PhD, FJCC
{"title":"Usefulness of hypochloremia at the time of discharge to predict prognosis in patients with chronic heart failure after hospitalization","authors":"Kayo Misumi MD, PhD ,&nbsp;Yuya Matsue MD, PhD ,&nbsp;Kazutaka Nogi MD, PhD ,&nbsp;Yudai Fujimoto MD ,&nbsp;Nobuyuki Kagiyama MD, PhD ,&nbsp;Takatoshi Kasai MD, PhD, FJCC ,&nbsp;Takeshi Kitai MD, PhD ,&nbsp;Shogo Oishi MD ,&nbsp;Eiichi Akiyama MD ,&nbsp;Satoshi Suzuki MD, PhD, FJCC ,&nbsp;Masayoshi Yamamoto MD, PhD ,&nbsp;Keisuke Kida MD, PhD, FJCC ,&nbsp;Takahiro Okumura MD, PhD, FJCC ,&nbsp;Maki Nogi MD, PhD ,&nbsp;Satomi Ishihara MD, PhD ,&nbsp;Tomoya Ueda MD, PhD ,&nbsp;Rika Kawakami MD, PhD, FJCC ,&nbsp;Yoshihiko Saito MD, PhD, FJCC ,&nbsp;Tohru Minamino MD, PhD, FJCC","doi":"10.1016/j.jjcc.2024.08.011","DOIUrl":"10.1016/j.jjcc.2024.08.011","url":null,"abstract":"<div><h3>Background</h3><div>Hypochloremia has been suggested as a strong marker of mortality in hospitalized patients with heart failure (HF). This study aimed to clarify whether incorporating hypochloremia into pre-existing prognostic models improved the performance of the models.</div></div><div><h3>Methods</h3><div>We tested the prognostic value of hypochloremia (&lt;97 mEq/L) measured at discharge in hospitalized patients with HF registered in the REALITY-AHF and NARA-HF studies. The primary outcome was 1-year mortality after discharge.</div></div><div><h3>Results</h3><div>Among 2496 patients with HF, 316 (12.6 %) had hypochloremia at the time of discharge, and 387 (15.5 %) deaths were observed within 1 year of discharge. The presence of hypochloremia was strongly associated with higher 1-year mortality compared to those without hypochloremia (log-rank: <em>p</em> &lt; 0.001), and this association remained even after adjustment for the Get With the Guideline–HF risk model (GWTG-HF), anemia, New York Heart Association (NYHA) classification, and log-brain natriuretic peptide (BNP) [hazard ratio (HR) 1.64; <em>p</em> &lt; 0.001]. Furthermore, adding hypochloremia to the prediction model composed of GWTG-HF + anemia + NYHA class + log-BNP yielded a numerically larger area under the curve (0.740 vs 0.749; <em>p</em> = 0.059) and significant improvement in net reclassification (0.159, <em>p</em> = 0.010).</div></div><div><h3>Conclusions</h3><div>Incorporating the presence of hypochloremia at discharge into pre-existing risk prediction models provides incremental prognostic information for hospitalized patients with HF.</div></div>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":"85 3","pages":"Pages 235-240"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current knowledge about infective endocarditis prevention among dentists affiliated with the Japanese Dental Association. 日本牙科协会所属牙医对预防感染性心内膜炎的现有认识。
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-02-25 DOI: 10.1016/j.jjcc.2025.02.018
Tamami Kadota, Tatsuya Akitomo, Yuko Iwamoto, Rena Okawa, Yusuke Mikasa, Takahiro Ohara, Masao Daimon, Chisato Izumi, Kenichi Yanagita, Ryota Nomura, Kazuhiko Nakano
{"title":"Current knowledge about infective endocarditis prevention among dentists affiliated with the Japanese Dental Association.","authors":"Tamami Kadota, Tatsuya Akitomo, Yuko Iwamoto, Rena Okawa, Yusuke Mikasa, Takahiro Ohara, Masao Daimon, Chisato Izumi, Kenichi Yanagita, Ryota Nomura, Kazuhiko Nakano","doi":"10.1016/j.jjcc.2025.02.018","DOIUrl":"10.1016/j.jjcc.2025.02.018","url":null,"abstract":"","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143523602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-echocardiography: Current status and future direction.
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-02-21 DOI: 10.1016/j.jjcc.2025.02.005
Yuki Sahashi, David Ouyang, Hiroyuki Okura, Nobuyuki Kagiyama
{"title":"AI-echocardiography: Current status and future direction.","authors":"Yuki Sahashi, David Ouyang, Hiroyuki Okura, Nobuyuki Kagiyama","doi":"10.1016/j.jjcc.2025.02.005","DOIUrl":"https://doi.org/10.1016/j.jjcc.2025.02.005","url":null,"abstract":"<p><p>Echocardiography, which provides detailed evaluations of cardiac structure and pathology, is central to cardiac imaging. Traditionally, the assessment of disease severity, treatment effectiveness, and prognosis prediction relied on detailed parameters obtained by trained sonographers and the expertise of specialists, which can limit access and availability. Recent advancements in deep learning and large-scale computing have enabled the automatic acquisition of parameters in a short time using vast amounts of historical training data. These technologies have been shown to predict the presence of diseases and future cardiovascular events with or without relying on quantitative parameters. Additionally, with the advent of large-scale language models, zero-shot prediction that does not require human labeling and automatic echocardiography report generation are also expected. The field of AI-enhanced echocardiography is poised for further development, with the potential for more widespread use in routine clinical practice. This review discusses the capabilities of deep learning models developed using echocardiography, their limitations, current applications, and research utilizing generative artificial intelligence technologies.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143537207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of glucagon-like peptide-1 receptor agonists in HFpEF and obesity without diabetes mellitus.
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-02-21 DOI: 10.1016/j.jjcc.2025.02.017
Aravinthan Vignarajah, Jia Yean Thong, Min Choon Tan, Nishanthi Vigneswaramoorthy, Senthil Anand, Justin Z Lee
{"title":"Effects of glucagon-like peptide-1 receptor agonists in HFpEF and obesity without diabetes mellitus.","authors":"Aravinthan Vignarajah, Jia Yean Thong, Min Choon Tan, Nishanthi Vigneswaramoorthy, Senthil Anand, Justin Z Lee","doi":"10.1016/j.jjcc.2025.02.017","DOIUrl":"10.1016/j.jjcc.2025.02.017","url":null,"abstract":"","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143482947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary anomalies in single ventricles: Insights from selective angiographic assessment.
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-02-17 DOI: 10.1016/j.jjcc.2025.02.009
Yuko Wakisaka, Kei Inai, Gen Harada, Seiji Asagai, Eriko Shimada
{"title":"Coronary anomalies in single ventricles: Insights from selective angiographic assessment.","authors":"Yuko Wakisaka, Kei Inai, Gen Harada, Seiji Asagai, Eriko Shimada","doi":"10.1016/j.jjcc.2025.02.009","DOIUrl":"10.1016/j.jjcc.2025.02.009","url":null,"abstract":"<p><strong>Background: </strong>Adults with congenital heart disease have a higher risk of coronary artery disease compared to the general population. However, there is limited information on coronary artery distribution in patients with a single ventricle (SV), which is important in understanding potential cardiovascular events. This study aimed to evaluate coronary artery morphology and anomalies in patients with SV based on selective coronary angiography (CAG).</p><p><strong>Methods: </strong>We performed a retrospective single-center study including 80 patients with SV [median age, 29 years (range 13-50); 54 % males] who underwent selective CAG at our institution between 2019 and 2023. Patients were classified into either single right or left ventricular (SRV and SLV) morphologies and categorized into D-, L-, and X-loops based on the rules of cardiovascular looping. Coronary artery morphology, dominance, and the abnormality of origin were evaluated.</p><p><strong>Results: </strong>Of the 80 SV patients, 56 had SRV and 24 had SLV. Patients with coronary artery looping surrounding the rudimentary chamber were more frequent in cases with D-loops. In patients with SV, right coronary artery dominance was observed in 70 %, and anomalous origins of coronary artery origins were found in 36.3 % of cases, with a higher frequency of L-loops. Overall, cardiovascular events were observed in patients with SV as follows: 46 % of patients had arrhythmias, 13 % had heart failure, and 8 % had thrombosis; there were no cardiovascular deaths. A single coronary artery was identified in 9 cases (11 %) of SV patients, exclusively in SRV, of which 2 cases (22 %) had arrhythmias and 1 case (11 %) had thrombus.</p><p><strong>Conclusion: </strong>Selective CAG revealed a high prevalence of coronary artery anomalies in patients with SV, emphasizing the importance of comprehensive assessment and long-term follow-up to manage cardiovascular risk in this patient population.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's reply to "How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation".
IF 2.5 3区 医学
Journal of cardiology Pub Date : 2025-02-15 DOI: 10.1016/j.jjcc.2025.02.015
Zheng-Qi Song, Xin-Yu Lu, Yu-Peng Xu, Hui Lin, Yi-He Chen
{"title":"Author's reply to \"How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation\".","authors":"Zheng-Qi Song, Xin-Yu Lu, Yu-Peng Xu, Hui Lin, Yi-He Chen","doi":"10.1016/j.jjcc.2025.02.015","DOIUrl":"10.1016/j.jjcc.2025.02.015","url":null,"abstract":"","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信